Page last updated: 2024-08-22

stavudine and Body Weight

stavudine has been researched along with Body Weight in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (28.57)18.2507
2000's12 (57.14)29.6817
2010's3 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atté, EF; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R1
Iseniyi, JO; Odeigah, L; Olatunji, PO; Olawumi, HO; Salami, AK1
Chaisson, RE; Charalambous, S; Churchyard, GJ; Fielding, KL; Grant, AD; Hoffmann, CJ; Innes, C1
Corbett, AH; Hosseinipour, MC; Kanyama, C; Kashuba, AD; Kazembe, P; Mkupani, P; Mwansambo, C; Nyirenda, J; Rezk, NL; Sichali, D; Tien, H; Weigel, R1
Burger, DM; Chintu, C; Cook, A; Ferrier, A; Fillekes, Q; Gibb, DM; Kabamba, D; Kankasa, C; Mulenga, V; Thomason, MJ; Walker, AS1
Bagenda, DS; Barlow-Mosha, LN; Butler, LM; Fowler, MG; Mubiru, MC; Mudiope, PK; Musoke, PM1
Bastin, J; Begriche, K; Fromenty, B; Guimont, MC; Igoudjil, A; Laigneau, JP; Lettéron, P; Maisonneuve, C; Pessayre, D1
Bressolle, F; Compagnucci, A; Faye, A; Giaquinto, C; Gibbs, D; Gomeni, R; Jacqz-Aigrain, E; Payen, S1
Bowonwatanuwong, C; Desakorn, V; Krudsood, S; Pitisuttithum, P; Tin, EE; Wilairatana, P1
D'Cruz, OJ; Erbeck, D; Uckun, FM1
Olatunji, PO; Olawumi, HO1
Cecelia, AJ; Kumarasamy, N; Mayer, K; Saghayam, S; Solomon, S; Wanke, C1
Bogner, J; Claas, GJ; Goebel, FD; Jülg, B1
Kamerman, PR; Mitchell, D; Weber, J1
Burger, DM; Chintu, C; Ewings, FM; Gibb, DM; Kabamba, D; Kankasa, C; L'homme, RF; Mulenga, V; Thomason, MJ; Walker, AS1
Church, JA; Dunkle, LM; Federici, ME; Goldsmith, JC; Harris, AT; Kaul, S; Kline, MW; Loewen, DF; Schultze, ME; Woods, L1
Skowron, G1
Adler, M; Anderson, RE; Cross, A; Dunkle, LM; Kriesel, D; Martin, RR; Smaldone, L; Wirtz, C1
Anderson, RE; Cross, A; Dunkle, LM; Hassett, J; Murray, HW; Sacks, HS; Sledz, S; Squires, KE; Weiss, W1
Briqnac, H; Miller, LK; Olson, PE; Wallace, MR1
Elmadfa, I; Jilma, B; Parschalk, B; Pernerstorfer-Schoen, H; Schindl, A; Schindler, K; Thoeny-Lampert, S; Tschachler, E; Wunderer, K1

Reviews

1 review(s) available for stavudine and Body Weight

ArticleYear
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
    The Journal of infectious diseases, 1995, Volume: 171 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine

1995

Trials

13 trial(s) available for stavudine and Body Weight

ArticleYear
Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Nigerian journal of clinical practice, 2008, Volume: 11, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; Hospitals, Teaching; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Stavudine; Treatment Outcome

2008
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa.
    AIDS (London, England), 2009, Aug-24, Volume: 23, Issue:13

    Topics: Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Female; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load

2009
Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
    Antiviral therapy, 2010, Volume: 15, Issue:1

    Topics: Adolescent; Anti-HIV Agents; Body Weight; Child; Child, Preschool; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drugs, Generic; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Malawi; Male; Nevirapine; Prospective Studies; Stavudine

2010
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Lamivudine; Male; Nevirapine; Stavudine; Viral Load; Zambia

2012
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2

    Topics: Aging; Bayes Theorem; Body Weight; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Models, Biological; Nelfinavir; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Stavudine

2005
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Stavudine

2005
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
    HIV medicine, 2006, Volume: 7, Issue:6

    Topics: Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Stavudine; Treatment Outcome

2006
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
    European journal of medical research, 2007, Feb-26, Volume: 12, Issue:2

    Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load

2007
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
    AIDS (London, England), 2008, Mar-12, Volume: 22, Issue:5

    Topics: Adolescent; Antiretroviral Therapy, Highly Active; Area Under Curve; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Female; HIV Infections; Humans; Infant; Infant, Newborn; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zambia

2008
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
    Pediatrics, 1995, Volume: 96, Issue:2 Pt 1

    Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Female; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Stavudine; Survival Rate; Zidovudine

1995
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
    The Journal of infectious diseases, 1995, Volume: 171 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine

1995
Design and implementation of the stavudine parallel-track program.
    The Journal of infectious diseases, 1995, Volume: 171 Suppl 2

    Topics: Adult; Body Weight; Double-Blind Method; Female; HIV Infections; Humans; Male; Peripheral Nervous System Diseases; Regression Analysis; Stavudine; Survival Rate

1995
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
    The Journal of infectious diseases, 1995, Volume: 171 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Female; HIV Core Protein p24; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; Stavudine; Survival Analysis

1995

Other Studies

8 other study(ies) available for stavudine and Body Weight

ArticleYear
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Organophosphonates; Rwanda; Stavudine; Tenofovir; Treatment Outcome; Weight Loss; Zidovudine

2009
The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.
    African health sciences, 2012, Volume: 12, Issue:3

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Male; Medication Adherence; Nevirapine; Stavudine; Time Factors; Treatment Outcome; Viral Load

2012
Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.
    Antiviral therapy, 2004, Volume: 9, Issue:5

    Topics: Aminoisobutyric Acids; Animals; Anti-HIV Agents; Body Weight; Homeostasis; Lipid Metabolism; Lipodystrophy; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Reverse Transcriptase Inhibitors; Stavudine; Thinness; Zidovudine

2004
Developmental safety profile of the anti-HIV agent stampidine in rabbits.
    Arzneimittel-Forschung, 2006, Volume: 56, Issue:2A

    Topics: Animals; Anti-HIV Agents; Body Weight; Capsules; Chemistry, Pharmaceutical; Dideoxynucleotides; Eating; Excipients; Female; Fetal Development; Gelatin; Pregnancy; Rabbits; Reproduction; Skeleton; Stavudine; Teratogens; Thymidine Monophosphate

2006
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-15, Volume: 44, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Weight; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Stavudine; Zidovudine

2007
Oral administration of stavudine induces hyperalgesia without affecting activity in rats.
    Physiology & behavior, 2007, Dec-05, Volume: 92, Issue:5

    Topics: Administration, Oral; Analysis of Variance; Animals; Antimetabolites; Behavior, Animal; Body Mass Index; Body Weight; Eating; Female; Hyperalgesia; Motor Activity; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Running; Stavudine

2007
Clinical experience with stavudine as salvage therapy in patients with advanced HIV disease.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiviral Agents; Body Weight; HIV Infections; Humans; Middle Aged; Salvage Therapy; Stavudine

1996
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Adult; Basal Metabolism; Body Composition; Body Weight; Case-Control Studies; Cohort Studies; Didanosine; Energy Metabolism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Viremia

1999